BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11219481)

  • 1. Comparison of the efficacy of extended-release clarithromycin tablets and amoxicillin/clavulanate tablets in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Fisher CL; Busman T; Olson CA
    Clin Ther; 2001 Jan; 23(1):72-86. PubMed ID: 11219481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III, randomized, double-blind study of clarithromycin extended-release and immediate-release formulations in the treatment of patients with acute exacerbation of chronic bronchitis.
    Adler JL; Jannetti W; Schneider D; Zhang J; Palmer R; Notario G
    Clin Ther; 2000 Dec; 22(12):1410-20. PubMed ID: 11192133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
    Riffer E; Spiller J; Palmer R; Shortridge V; Busman TA; Valdes J
    Curr Med Res Opin; 2005 Jan; 21(1):61-70. PubMed ID: 15881476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of clarithromycin modified release and amoxicillin/clavulanic acid in the treatment of acute exacerbation of chronic bronchitis.
    Martinot JB; Carr WD; Cullen S; Heredia Budo JL; Bauer K; MacLeod C; Sanguinetti CM; van Veldhuizen WC;
    Adv Ther; 2001; 18(1):1-11. PubMed ID: 11512528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ; Perry CM
    Am J Respir Med; 2003; 2(2):175-201. PubMed ID: 14720016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerability of extended-release clarithromycin.
    Guay DR; Gustavson LE; Devcich KJ; Zhang J; Cao G; Olson CA
    Clin Ther; 2001 Apr; 23(4):566-77. PubMed ID: 11354390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Notario G; Spiller J; Palmer R; Busman T
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis.
    Sher LD; McAdoo MA; Bettis RB; Turner MA; Li NF; Pierce PF
    Clin Ther; 2002 Feb; 24(2):269-81. PubMed ID: 11911557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open-label, randomized, multicenter, comparative study of the efficacy and safety of 7 days of treatment with clarithromycin extended-release tablets versus clarithromycin immediate-release tablets for the treatment of patients with acute bacterial exacerbation of chronic bronchitis.
    Weiss K; Vanjaka A;
    Clin Ther; 2002 Dec; 24(12):2105-22. PubMed ID: 12581548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M; Busman TA; Norris S; Notario GF
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multinational, multicentre, non-blinded, randomized study of moxifloxacin oral tablets compared with co-amoxiclav oral tablets in the treatment of acute exacerbation of chronic bronchitis.
    Schaberg T; Ballin I; Huchon G; Bassaris H; Hampel B; Reimnitz P;
    J Int Med Res; 2001; 29(4):314-28. PubMed ID: 11675905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis.
    Dubois J; Saint-Pierre C; Tremblay C
    Ear Nose Throat J; 1993 Dec; 72(12):804-10. PubMed ID: 8313865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis.
    Aubier M; Aldons PM; Leak A; McKeith DD; Leroy B; Rangaraju M; Bienfait-Beuzon C
    Respir Med; 2002 Nov; 96(11):862-71. PubMed ID: 12418583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of a new ciprofloxacin suspension compared with co-amoxiclav tablets in the treatment of acute exacerbations of chronic bronchitis.
    Read RC; Kuss A; Berrisoul F; Kearsley N; Torres A; Kubin R
    Respir Med; 1999 Apr; 93(4):252-61. PubMed ID: 10464889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study.
    Fogarty CM; Cyganowski M; Palo WA; Hom RC; Craig WA
    Clin Ther; 2002 Nov; 24(11):1854-70. PubMed ID: 12501879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children.
    McCarty JM; Phillips A; Wiisanen R
    Pediatr Infect Dis J; 1993 Dec; 12(12 Suppl 3):S122-7. PubMed ID: 8295813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.